Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Non-cash Items (2017 - 2025)

Historic Non-cash Items for Q32 Bio (QTTB) over the last 9 years, with Q3 2025 value amounting to $1.1 million.

  • Q32 Bio's Non-cash Items fell 9820.37% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 9820.37%. This contributed to the annual value of $12380.0 for FY2024, which is 9982.47% down from last year.
  • Latest data reveals that Q32 Bio reported Non-cash Items of $1.1 million as of Q3 2025, which was down 9820.37% from $1.0 million recorded in Q2 2025.
  • Over the past 5 years, Q32 Bio's Non-cash Items peaked at $62.8 million during Q3 2024, and registered a low of $10712.0 during Q4 2023.
  • In the last 5 years, Q32 Bio's Non-cash Items had a median value of $1.6 million in 2021 and averaged $6.6 million.
  • Its Non-cash Items has fluctuated over the past 5 years, first surged by 95527.25% in 2023, then tumbled by 9820.37% in 2025.
  • Q32 Bio's Non-cash Items (Quarter) stood at $2.1 million in 2021, then plummeted by 76.17% to $493000.0 in 2022, then crashed by 97.83% to $10712.0 in 2023, then increased by 15.57% to $12380.0 in 2024, then soared by 9016.02% to $1.1 million in 2025.
  • Its Non-cash Items stands at $1.1 million for Q3 2025, versus $1.0 million for Q2 2025 and $12380.0 for Q4 2024.